TY - JOUR
T1 - A Survival Analysis of Rural-Urban Disparities in COVID-19 Vaccination Uptake in the United States
AU - Datta, Biplab Kumar
AU - Jaremski, Jennifer E.
AU - Ansa, Benjamin E.
AU - Odhiambo, Lorriane
AU - Clary, Catherine
AU - Islam, K. M.Monirul
AU - Johnson, J. Aaron
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - Purpose: Though urban-rural disparities in COVID-19 vaccination coverage was documented at a point of time, little is known on the evolution of vaccination uptake over time. This study, using individual level time-to-event data, intend to assess the differences in monthly progression of vaccination uptake among U.S. adults by urban/rural residence. Design: Survival analysis. Setting: Urban and rural areas in 29 U.S. states. Subjects: 135,969 adults aged 18+ years. Measures: Time (in months) to receive the first dose of COVID-19 vaccine since the U.S. Food and Drug Administration (FDA) Emergency Use Authorization of Pfizer-BioNTech- and Moderna- COVID-19 Vaccine in December 2020. Analysis: Kaplan-Meier survivor functions and stratified Cox proportional hazard models were estimated for the event of being vaccinated by urban/rural residence for 25 months starting from December 2020. Monthly survival probabilities for urban- and rural- adults were further assessed within certain demographic and socioeconomic groups. Results: We found a gradual divergence of COVID-19 vaccination uptake in favor of urban adults, which was robust across sex, age groups, race and ethnicity, education, and income levels. In April 2021, after vaccine eligibility was expanded, 42.2% adults in urban and 53.3% adults in rural areas were unvaccinated. While only 19.3% urban adults remained unvaccinated in December 2022, this rate was 32.5% among rural adults. Compared to their urban counterparts, rural adults were 0.77 (95% CI: 0.76 - 0.79) times as likely to receive the first dose of COVID-19 vaccine. Conclusions: Time-to-event analysis of vaccination against COVID-19 indicated a lower uptake among rural adults, which was persistent across different demographic and socioeconomic groups.
AB - Purpose: Though urban-rural disparities in COVID-19 vaccination coverage was documented at a point of time, little is known on the evolution of vaccination uptake over time. This study, using individual level time-to-event data, intend to assess the differences in monthly progression of vaccination uptake among U.S. adults by urban/rural residence. Design: Survival analysis. Setting: Urban and rural areas in 29 U.S. states. Subjects: 135,969 adults aged 18+ years. Measures: Time (in months) to receive the first dose of COVID-19 vaccine since the U.S. Food and Drug Administration (FDA) Emergency Use Authorization of Pfizer-BioNTech- and Moderna- COVID-19 Vaccine in December 2020. Analysis: Kaplan-Meier survivor functions and stratified Cox proportional hazard models were estimated for the event of being vaccinated by urban/rural residence for 25 months starting from December 2020. Monthly survival probabilities for urban- and rural- adults were further assessed within certain demographic and socioeconomic groups. Results: We found a gradual divergence of COVID-19 vaccination uptake in favor of urban adults, which was robust across sex, age groups, race and ethnicity, education, and income levels. In April 2021, after vaccine eligibility was expanded, 42.2% adults in urban and 53.3% adults in rural areas were unvaccinated. While only 19.3% urban adults remained unvaccinated in December 2022, this rate was 32.5% among rural adults. Compared to their urban counterparts, rural adults were 0.77 (95% CI: 0.76 - 0.79) times as likely to receive the first dose of COVID-19 vaccine. Conclusions: Time-to-event analysis of vaccination against COVID-19 indicated a lower uptake among rural adults, which was persistent across different demographic and socioeconomic groups.
KW - COVID-19
KW - rural populations
KW - socioeconomic disparities in health
KW - urban populations
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=85209225788&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85209225788&partnerID=8YFLogxK
U2 - 10.1177/08901171241300136
DO - 10.1177/08901171241300136
M3 - Article
AN - SCOPUS:85209225788
SN - 0890-1171
JO - American Journal of Health Promotion
JF - American Journal of Health Promotion
ER -